Generic Semaglutide Availability's Cost-Effectiveness Analyzed for Type 2 Diabetes Patients
Implications of Generic Semaglutide Availability on the Cost-Effectiveness of GLP-1RA for Guideline-Indicated Patients With Type 2 Diabetes.
Abstract
This study models the potential cost-effectiveness of generic semaglutide for Type 2 Diabetes management, considering its future market entry.